Janux Therapeutics, Inc. (JANX)
Stock Price: $27.60 USD
-0.81 (-2.85%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | |
|---|---|---|---|
| Revenue | - | - | |
| Selling, General & Admin | 1.80 | 0.77 | |
| Research & Development | 3.04 | 3.00 | |
| Operating Expenses | 4.84 | 3.77 | |
| Operating Income | -4.84 | -3.77 | |
| Interest Expense / Income | 0.21 | 0.23 | |
| Other Expense / Income | 1.74 | 0.00 | |
| Pretax Income | -6.78 | -4.00 | |
| Net Income | -6.78 | -4.00 | |
| Shares Outstanding (Basic) | 0.92 | 0.67 | |
| Shares Outstanding (Diluted) | 0.92 | 0.67 | |
| Shares Change | 36.71% | - | |
| EPS (Basic) | -7.41 | -5.98 | |
| EPS (Diluted) | -7.41 | -5.98 | |
| Free Cash Flow Per Share | -4.77 | -5.72 | |
| EBITDA | -6.57 | -3.77 | |
| EBIT | -6.58 | -3.77 |